Media Professonals
Immediate access to important information, including the latest news and public relations contacts.
Special Announcements
Related Links
Some of these documents are in PDF (portable document format). PDF files require Adobe acrobat Reader; Click here to download this free program.
2008 News
Click on a headline below to view the full news story.
You may also search our news archive by using keywords or dates (example: 4/25/2006).
July 23, 2008
Wyeth Reports Earnings Results for the 2008 Second Quarter and First Half and Raises Earnings Guidance
July 22, 2008
Wyeth Pearl River Facility Earns OSHA VPP Star; 2,000th Workplace Recognized in the U.S.
July 14, 2008
Two New Jersey Hormone Therapy Lawsuits Dismissed
June 26, 2008
Wyeth Declares Common and Preferred Stock Dividends
June 18, 2008
Amgen and Wyeth Statement on Outcome of Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting
June 5, 2008
Fort Dodge Animal Health Announces Reintroduction of Proheart 6 to the U.S. Veterinary Market
May 28, 2008
New England Journal Of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
May 23, 2008
Wyeth Receives Approvable Letter From FDA for Bazedoxifene For the Treatment of Postmenopausal Osteoporosis
April 24, 2008
Wyeth Holds Annual Meeting of Stockholders
April 24, 2008
More Clinical Data Required to Support European Approval of CAP Indication for TYGACIL
April 24, 2008
Progenics and Wyeth Announce FDA has Approved Relistor
March 20, 2008
Fort Dodge's 'Mosquito Shot' Offers Convenient Protection Against Dangerous Mosquito-Borne Illnesses
March 12, 2008
Wyeth and Progenics Provide Update on Phase 3 Clinical Trial of Intravenous Methylnaltrexone for Postoperative Ileus
March 12, 2008
More Clinical Data Required to Support European Approval of Desvenlafaxine as a Potential Treatment for Vasomotor Symptoms
March 10, 2008
Wyeth to Invest $280 Million to Build State-of-the-Art Nutritional Manufacturing Facility in China
March 4, 2008
WHI Findings Published in JAMA Do Not Affect Clinical Guidance for the Appropriate Use of Hormone Therapy
February 29, 2008
FDA Approves Pristiq for the Treatment of Adult Patients with Major Depressive Disorder
February 29, 2008
Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds
February 28, 2008
Wyeth Announces Executive Change in Finance Organization -- John C. Kelly Named New Controller
February 21, 2008
Wyeth's XYNTHA Approved by FDA for Treatment of Hemophilia A
February 19, 2008
Wyeth Wins Thimerosal-Autism Case in Maryland Court
February 15, 2008
Wyeth Consumer Healthcare Names New Head of Global R&D
February 5, 2008
Wyeth Announces Election of Timothy P. Cost as Senior Vice President, Corporate Affairs
February 4, 2008
Wyeth to Present at the Merrill Lynch 2008 Global Pharmaceutical, Biotechnology and Medical Device Conference
January 30, 2008
Wyeth Announces Launch of Own Generic Version of Protonix
January 28, 2008
Fort Dodge Animal Health and the American Association of Equine Practitioners Launch Educational Web Site
January 25, 2008
Wyeth Declares Common and Preferred Stock Dividends
January 22, 2008
Wyeth Pharmaceuticals Named as Top 10 Pipeline for Fourth Consecutive Year by R&D Directions Magazine
January 21, 2008
Wyeth and Teva Pharmaceuticals Extend the Standstill Period Relating to Teva's Launch of Generic Pantoprazole
January 16, 2008
New Study Reports Enbrel (etanercept) Significantly Improved Moderate to Severe Plaque Psoriasis in Children and Adolescents
January 14, 2008
Thimerosal-Autism Link Rejected by Maryland Court
January 10, 2008
Progenics and Wyeth Announce NDA Review Period for Subcutaneous Methylnaltrexone Extended by Three Months
January 3, 2008